EQT
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
IPO offers CVC chance to become multi-asset consolidator
Potential IPO also offers monetisation solution for founders and GP stakes investor Blue Owl
EQT exits Schuelke to Athos-led consortium
The Munich-based family office has been an LP in EQT's funds; joined recent co-investment tickets
EQT Mid Market exits Ellab to Novo
Sale of Danish validation solutions group follows exit of BBS Automation as GP divests mid-market fund
EQT mandates Bank of America for Schuelke sale
GP bought the Germany-based infection prevention firm from France’s Air Liquide in 2020 via EQT VIII
ESI Group draws EQT, Hg, Thoma Bravo interest
Listed French industrial software maker has drawn wide interest from sponsors and strategic players
EQT launches semi-liquid strategy for individual investors
Strategy will focus on PE and infrastructure and will be led by ex-Partners Group exec William Vettorato
Wellspect auction in final stretch with Blackstone, EQT and KKR to battle it out
Owner Dentsply launched a process to sell the Swedish bowel and bladder control products specialist in February
EQT weighs options for infection prevention firm Schuelke
Sponsor assesses quick flip for German company, acquired via EQT VIII in 2020
Germany's DFL to collect NBOs for EUR 3bn media rights stake
Large-cap sponsors including Advent, Blackstone, Bridgepoint, CVC, EQT and KKR expected to bid today
EQT exits Kfzteile24 to management, investor consortium
Sale of German car parts e-retailer wraps up EQT’s inaugural 2013-vintage Mid Market fund
Wellspect bidders CVC, KKR, PAI, EQT expected to progress into second round
US trade owner attempted a previous sale for the Swedish bladder and bowel-control products specialist in 2018
ECI reaps 2.7x return on 4ways sale to EQT-backed Evidia
Sale process for UK-based teleradiology platform had been running since September 2022
Large-cap sponsors circle Qiagen bioinformatics arm ahead of indicative bids
Potential PE bidders are assessing performance and market share of the Netherlands-headquartered business
EQT closes LSP Dementia on EUR 260m hard cap
Series A-focused fund exceeded its EUR 100m target and extended fundraising after increased LP interest in its strategy
EQT Growth acquires GotPhoto, marking fund's ninth deal
Sponsor sees attractive M&A opportunities for the growth of the Germany-based software platform for photographers
EQT Growth in active deployment with EUR 100m IntegrityNext deal
Sponsor to support organic growth of Munich-based ESG software group via inhouse digital and sustainability teams
EQT faces selldown dilemma as realisation pressure dawns
Swedish GP still holds large stakes in Azelis, Suse more than 18 months after listings; could look to selldown in H2 2023
Carlyle private equity fundraising slumps behind peers
Sponsor remains on the road for its eighth flagship fund amid turmoil at CEO-level, with fundraising lagging behind peers KKR and EQT
The Bolt-Ons Digest – 26 January 2023
Unquoteтs selection of the latest add-ons, with ICG's Circet, Five Arrows' Mintec, Carlyle's Jagex, and more
German health minister's 'locust sponsors' comments spook live healthcare deals
New entrants scared by remarks on limiting profits; existing investors expected to rush to complete bolt-ons
EQT on track for 2023 final close for Fund X
GP has so far raised more than EUR 16bn for the vehicle against EUR 20bn target
Going, going, not gone: PE auctions bid for relevance amid risk-off environment
With a debt financing drought and macro woes denting exits, GPs are adapting the traditional M&A auction in favour of more flexible bilateral negotiations to get deals across the line
EQT weighs options for Open Systems including partial sale
Bank of America to prepare sale of the group's secure access service edge network division